Compare BXMT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BXMT | ADMA |
|---|---|---|
| Founded | 1966 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.7B |
| IPO Year | N/A | N/A |
| Metric | BXMT | ADMA |
|---|---|---|
| Price | $19.81 | $19.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $20.33 | ★ $28.50 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 02-11-2026 | 11-05-2025 |
| Dividend Yield | ★ 9.49% | N/A |
| EPS Growth | N/A | ★ 205.35 |
| EPS | 0.62 | ★ 0.86 |
| Revenue | $393,335,000.00 | ★ $488,559,000.00 |
| Revenue This Year | N/A | $22.19 |
| Revenue Next Year | $18.84 | $23.71 |
| P/E Ratio | $31.84 | ★ $22.52 |
| Revenue Growth | N/A | ★ 27.63 |
| 52 Week Low | $16.51 | $13.50 |
| 52 Week High | $21.24 | $25.67 |
| Indicator | BXMT | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 55.86 |
| Support Level | $19.68 | $18.33 |
| Resistance Level | $20.23 | $19.94 |
| Average True Range (ATR) | 0.30 | 0.63 |
| MACD | -0.10 | -0.17 |
| Stochastic Oscillator | 20.66 | 45.11 |
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.